Aifg Consultants Ltd. Regeneron Pharmaceuticals, Inc. Transaction History

Aifg Consultants Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$902.69 - $993.35 $1,805 - $1,986	2 Added 0.45%	444 $428 Million
Q4 2023 Jan 31, 2024	BUY	$775.18 - $881.7 $2,325 - $2,645	3 Added 0.68%	442 $388 Million
Q3 2023 Nov 08, 2023	BUY	$692.45 - $844.37 $303,985 - $370,678	439 New	439 $365 Million

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Aifg Consultants Ltd., based on Form 13F filings with the SEC.

Stay updated on Aifg Consultants Ltd. with notifications on news.